Treatment of Nocturnal Enuresis in Children
The first-line treatments for monosymptomatic nocturnal enuresis in children are enuresis alarm therapy and desmopressin, with behavioral strategies as foundational interventions. 1
Initial Evaluation
Assess for:
- Pattern of bedwetting
- Daytime symptoms (to distinguish monosymptomatic from non-monosymptomatic enuresis)
- Family history of enuresis
- Sleep patterns
- Fluid intake patterns
- Bowel habits (constipation can worsen enuresis)
- Developmental history
- Psychological stressors
Laboratory evaluation:
- Urinalysis and urine culture (to rule out UTI, diabetes)
- Consider fasting blood glucose if polyuria/polydipsia present
Treatment Algorithm
Step 1: Behavioral Interventions
- Establish regular voiding schedule
- Limit evening fluid intake (especially 1-2 hours before bedtime)
- Avoid caffeinated beverages
- Create a dry night chart with positive reinforcement
- Involve child in changing wet bedding (not as punishment)
- Regular toileting before bedtime
Step 2: First-line Active Treatments
Option A: Enuresis Alarm
- Most effective long-term solution with lowest relapse rates
- Continue until 14 consecutive dry nights
- Regular monitoring appointments (at least every 3 weeks)
- Success rate of approximately 50-70%
Option B: Desmopressin
- Dosage: 0.2-0.4 mg tablets or 120-240 μg melt formulation
- Administration: 1 hour before bedtime (tablets) or 30-60 minutes before bedtime (melt)
- Important safety measures:
- Restrict evening fluid intake to 200 ml or less
- No fluid intake after medication until morning
- Schedule regular drug holidays (at least 2 weeks every 3 months)
- Success rate of approximately 30-40% with significant reduction in wet nights
Step 3: For Treatment-Resistant Cases
Option A: Combination Therapy
- Combine alarm therapy with desmopressin
- May be more effective than either treatment alone
Option B: Add Anticholinergics
- Consider if standard treatments fail
- Options:
- Tolterodine (2 mg at bedtime)
- Oxybutynin (5 mg at bedtime)
- Propiverine (0.4 mg/kg at bedtime)
- Important: Exclude or treat constipation before starting anticholinergics
- Monitor for side effects, especially constipation
Option C: Imipramine (Third-line)
- Only after other treatments have failed
- Dosage:
- Children 6 years and older: 25 mg/day
- Children over 12 years: up to 50 mg/day
- Safety concerns:
- Potentially cardiotoxic
- Keep medication securely locked
- Consider ECG before treatment if family history of cardiac issues
- Do not exceed 2.5 mg/kg/day 2
- Regular drug holidays to assess continued need
Common Pitfalls to Avoid
Starting treatment too early: Treatment should not begin before age 6 years 1
Neglecting comorbid conditions:
- Untreated constipation significantly reduces treatment success
- ADHD and other neuropsychiatric disorders may complicate treatment
Punitive approaches: These worsen psychological impact and decrease treatment adherence
Premature discontinuation: High relapse rates occur with early stopping, especially with medication
Water intoxication risk: Can occur if desmopressin is combined with excessive fluid intake
Focusing only on medication: Neglecting behavioral strategies reduces effectiveness
Special Considerations
- The spontaneous resolution rate is only 14-16% annually 1, justifying active treatment
- Simple behavioral methods may be tried first before more demanding interventions like alarms or medications 3
- For children with non-monosymptomatic enuresis (daytime symptoms present), additional evaluation by a specialist may be needed
- Regular follow-up using a wet/dry night calendar helps monitor progress and maintain motivation
Remember that nocturnal enuresis can significantly impact a child's self-esteem and social functioning, making effective treatment important for psychological well-being as well as dryness.